Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus.

Shoji R, Tazawa H, Kuroda S, Nishiyama T, Kajiwara Y, Yamada M, Nagai Y, Inoue H, Hashimoto N, Kikuchi S, Yoshida R, Umeda Y, Urata Y, Kagawa S, Fujiwara T

Open source

DOI
10.1016/j.omton.2026.201180
Published
2026 Jun 18
Container
Molecular therapy. Oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omton.2026.201180,
  title = {Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus.},
  author = {Shoji R and Tazawa H and Kuroda S and Nishiyama T and Kajiwara Y and Yamada M and Nagai Y and Inoue H and Hashimoto N and Kikuchi S and Yoshida R and Umeda Y and Urata Y and Kagawa S and Fujiwara T},
  year = {2026},
  journal = {Molecular therapy. Oncology},
  doi = {10.1016/j.omton.2026.201180},
  url = {https://doi.org/10.1016/j.omton.2026.201180}
}

RIS

TY  - JOUR
TI  - Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus.
AU  - Shoji R
AU  - Tazawa H
AU  - Kuroda S
AU  - Nishiyama T
AU  - Kajiwara Y
AU  - Yamada M
AU  - Nagai Y
AU  - Inoue H
AU  - Hashimoto N
AU  - Kikuchi S
AU  - Yoshida R
AU  - Umeda Y
AU  - Urata Y
AU  - Kagawa S
AU  - Fujiwara T
PY  - 2026
JO  - Molecular therapy. Oncology
DO  - 10.1016/j.omton.2026.201180
UR  - https://doi.org/10.1016/j.omton.2026.201180
ER  - 

APA

R, S., H, T., S, K., T, N., Y, K., M, Y., Y, N., H, I., N, H., S, K., R, Y., Y, U., Y, U., S, K., & T, F. (2026). Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus.. Molecular therapy. Oncology. https://doi.org/10.1016/j.omton.2026.201180

Source records